Stem cell transplantation before birth – a realistic option for treatment of osteogenesis imperfecta?

@article{Westgren2015StemCT,
  title={Stem cell transplantation before birth – a realistic option for treatment of osteogenesis imperfecta?},
  author={Magnus Westgren and Cecilia G{\"o}therstr{\"o}m},
  journal={Prenatal Diagnosis},
  year={2015},
  volume={35},
  pages={827 - 832}
}
Osteogenesis imperfecta (OI) is characterized by severe bone deformities, growth retardation and bones that break easily, often from little or no apparent cause. OI is a genetic disorder primarily with defective type I collagen with a wide spectrum of clinical expression. In the more severe cases, it can be diagnosed before birth. 
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
TLDR
The main goals of treatment in OI are to decrease fracture incidence, relieve bone pain, and promote mobility and growth, utilizing pharmacological interventions, physical therapy, orthopedic surgery, and monitoring nutrition with appropriate calcium and vitamin D supplementation. Expand
Review ArticleMesenchymal Stem Cells and Orthopaedics (A Current Concept)
TLDR
This review summarizes recent findings regarding the potential clinical use of Mesenchymal Stem Cells (MSCs) in Nonunions, Osteogenesis imperfect, Human Cartilage defects, osteoarthritis and Rheumatoid arthritis to provide a better understanding of the issue engineering with stem cell research, as well as the potential therapeutic purpose of these cells in orthopedic surgery. Expand
Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases
TLDR
It is recommended that patients with rare skeletal disorders are treated and monitored in highly specialized centers, which guarantees the greatest safety for the individual patient and offers the possibility of collecting data to further improve treatment strategies for these rare conditions. Expand
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches
TLDR
Stem cell therapy of osteoporosis, as a therapeutic strategy, offers the promise of an increase in osteoblast differentiation and thus reversing the shift towards bone resorption in osteoporeosis. Expand
Pathophysiology and therapeutic options in osteogenesis imperfecta: an update
TLDR
This work is licensed under the Creative Commons Attribution – Non Commercial (unported, v3.0) License and the full terms of this license are available at https://www.dovepress.com/terms.php. Expand
Reverse total shoulder arthroplasty in a patient with osteogenesis imperfecta type I complicated by a proximal humeral enchondroma: a case report and review of the literature
A 60-year-old right hand–dominant woman employed as a nurse was diagnosed with osteogenesis imperfecta type I as a child after sustaining multiple fragility fractures including 3 to her proximalExpand
Advances in the prenatal diagnosis of monogenic disorders
TLDR
How new technologies, largely based on sequencing, are broadening the scope of prenatal diagnosis, extending availability to more families and making it safer by exploiting the presence of cell-free fetal DNA in maternal plasma is explored. Expand
Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities
TLDR
The value of whole exome sequencing in fetuses with sonographic abnormalities but normal microarray analysis is investigated. Expand
Transcription factor ZNF25 is associated with osteoblast differentiation of human skeletal stem cells
TLDR
It is shown that the uncharacterized transcription factor, ZNF25, is associated with differentiation of hMSC to osteoblasts and exhibits nuclear localization and is expressed in osteoblastic and osteocytic cells in vivo. Expand
Syddansk Universitet Transcription factor ZNF 25 is associated with osteoblast differentiation of human skeletal stem cells
Background: The differentiation of human bone marrow derived skeletal stem cells (known as human bone marrow stromal or mesenchymal stem cells, hMSCs) into osteoblasts involves the activation of aExpand
...
1
2
3
...

References

SHOWING 1-10 OF 80 REFERENCES
Management of osteogenesis imperfecta in pregnancy. A case report.
TLDR
A case report and literature is presented and the prenatal diagnosis, evaluation criteria and guidelines for delivery of osteogenesis imperfecta are discussed. Expand
Management of osteogenesis imperfecta in pregnancy. A case report.
TLDR
A case report and literature is presented and the prenatal diagnosis, evaluation criteria and guidelines for delivery of osteogenesis imperfecta are discussed. Expand
[Prenatal diagnosis of osteogenesis imperfecta].
TLDR
The authors report a prenatal diagnosis of osteogenesis imperfecta or Porak and Durante disease, in which the child survived, and ultrasonography remains the investigation of choice, possibly helped by X-ray of the uterine contents. Expand
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.
TLDR
Clinical responses of the first children to undergo allogeneic bone marrow transplantation (BMT) for severe osteogenesis imperfecta, a genetic disorder characterized by defective type I collagen, osteopenia, bone fragility, severe bony deformities, and growth retardation, are described. Expand
Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
TLDR
The data suggest that exogenous cells decrease bone brittleness and BV by directly differentiating to osteoblasts and indirectly stimulating host chondrogenesis and osteogenesis, and the placenta is a practical source of stem cells for the treatment of OI. Expand
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
TLDR
Improvements in total body bone mineral content and growth velocity were associated with increases in growth velocity and reduced frequencies of bone fracture, indicating the feasibility of allogeneic bone marrow transplantation in the treatment of osteogenesis imperfecta and perhaps other mesenchymal stem cell disorders as well. Expand
Osteogenesis imperfecta: prospects for molecular therapeutics.
TLDR
The present review will provide an update of OI clinical and molecular data and outline gene therapeutic approaches being tested on OI murine models for this disorder, especially mutation suppression by hammerhead ribozymes. Expand
Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation
TLDR
Identification of these multiple causative defects has provided crucial information for accurate genetic counseling, inspired a recently proposed functional grouping of osteogenesis imperfecta types by shared mechanism to simplify current nosology, and has prodded investigations into common pathways in osteogenesis perfecta. Expand
New genes in bone development: what's new in osteogenesis imperfecta.
TLDR
Three recessive OI types arise from defects in any of the components of the collagen prolyl 3-hydroxylation complex (CRTAP, P3H1, CyPB), which modifies the collagen α1(I)Pro986 residue. Expand
Recessive osteogenesis imperfecta: Clinical, radiological, and molecular findings
  • M. Rohrbach, C. Giunta
  • Medicine
  • American journal of medical genetics. Part C, Seminars in medical genetics
  • 2012
TLDR
This article reviews the recently characterized forms of recessive OI, focusing in particular on their clinical and molecular findings, and on their radiological characterisation. Expand
...
1
2
3
4
5
...